Skip to content

Clinical trials

Multiple Sclerosis trials in Italy with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Not applicable Country / region: Italy Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20113
20121
20133
20146
20154
20163
20176
20189
20198
20209
20218
20224
202315
20249
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status34
Recruiting20
Active, not recruiting9
Not yet recruiting5
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Don Carlo Gnocchi ETS20
University Hospital of Ferrara11
IRCCS Centro Neurolesi Bonino Pulejo8
Universita di Verona7
I.R.C.C.S. Fondazione Santa Lucia5
Fondazione Italiana Sclerosi Multipla4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS4
IRCCS San Camillo, Venezia, Italy4
IRCCS San Raffaele4
Istituti Clinici Scientifici Maugeri SpA3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis104
Parkinson Disease16
Stroke10
Cognitive Dysfunction9
Nervous System Diseases6
Multiple Sclerosis, Relapsing-Remitting5
Fatigue4
Spinal Cord Injuries4
Cognition Disorders3
Alzheimer Disease2

Trials

Showing 1 to 25 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.